BIOATLA, INC. Payments to Acquire Machinery and Equipment
BIOATLA, INC. (BCAB) reported Payments to Acquire Machinery and Equipment of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMachineryAndEquipment · last filed 2025-05-06
- BIOATLA, INC. payments to acquire machinery and equipment for the quarter ending 2025-03-31 was $0.00.
- BIOATLA, INC. payments to acquire machinery and equipment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOATLA, INC. payments to acquire machinery and equipment for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOATLA, INC. payments to acquire machinery and equipment for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOATLA, INC. payments to acquire machinery and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BIOATLA, INC. payments to acquire machinery and equipment for fiscal 2023 was $98.00K, a 63.43% decline from fiscal 2022.
- BIOATLA, INC. payments to acquire machinery and equipment for fiscal 2022 was $268.00K, a 71.00% decline from fiscal 2021.
- BIOATLA, INC. payments to acquire machinery and equipment for fiscal 2021 was $924.00K, a 56.61% increase from fiscal 2020.
| Period end | Payments to Acquire Machinery and Equipment 3 month | Payments to Acquire Machinery and Equipment 6 month | Payments to Acquire Machinery and Equipment 9 month | Payments to Acquire Machinery and Equipment 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-05-06 | $0.00 derived: sum of 3 quarters · filed 2025-05-06 | $0.00 derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | $0.00 10-K · filed 2025-03-28 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $8.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $8.00K derived: sum of 3 quarters · filed 2025-05-06 | $33.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $8.00K derived: sum of 2 quarters · filed 2025-05-06 | $33.00K derived: sum of 3 quarters · filed 2025-05-06 | $48.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $33.00K derived: sum of 2 quarters · filed 2025-03-28 | $48.00K derived: sum of 3 quarters · filed 2025-03-28 | $98.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $40.00K derived: sum of 2 quarters · filed 2024-11-07 | $90.00K 10-Q · filed 2024-11-07 | $121.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $65.00K 10-Q · filed 2024-08-08 | $96.00K derived: sum of 3 quarters · filed 2024-08-08 | $154.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $50.00K 10-Q · filed 2024-05-14 | $81.00K derived: sum of 2 quarters · filed 2024-05-14 | $139.00K derived: sum of 3 quarters · filed 2024-05-14 | $308.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $89.00K derived: sum of 2 quarters · filed 2024-03-26 | $258.00K derived: sum of 3 quarters · filed 2024-03-26 | $268.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $227.00K derived: sum of 2 quarters · filed 2023-11-07 | $237.00K 10-Q · filed 2023-11-07 | $326.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $179.00K 10-Q · filed 2023-08-01 | $268.00K derived: sum of 3 quarters · filed 2023-08-01 | $367.00K derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-11 | $99.00K derived: sum of 2 quarters · filed 2023-05-11 | $198.00K derived: sum of 3 quarters · filed 2023-05-11 | $433.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $188.00K derived: sum of 2 quarters · filed 2023-03-23 | $423.00K derived: sum of 3 quarters · filed 2023-03-23 | $924.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $334.00K derived: sum of 2 quarters · filed 2022-11-04 | $835.00K 10-Q · filed 2022-11-04 | $1.23M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $736.00K 10-Q · filed 2022-08-09 | $1.13M derived: sum of 3 quarters · filed 2022-08-09 | $1.24M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $501.00K 10-Q · filed 2022-05-05 | $896.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.00M derived: sum of 3 quarters · filed 2022-05-05 | $1.07M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $504.00K derived: sum of 2 quarters · filed 2022-02-28 | $570.00K derived: sum of 3 quarters · filed 2022-02-28 | $590.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $175.00K derived: sum of 2 quarters · filed 2021-11-15 | $195.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $86.00K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $1.51M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |